Variable | Group C (n = 26) | Group T (n = 26) | Group TR (n = 26) | P |
---|---|---|---|---|
Age (years) | 60.6 ± 8.2 | 61.5 ± 8.2 | 61.5 ± 8.1 | 0.899 |
Male/Female (n) | 13/13 | 16/10 | 18/8 | 0.362 |
BMI (kg/m2) | 23.6 ± 2.2 | 23.4 ± 2.0 | 23.9 ± 2.6 | 0.697 |
ASA I/II/III (n) | 1/21/4 | 1/18/7 | 0/19/7 | 0.691 |
Clinical Stage I/II (n) | 14/12 | 10/16 | 13/13 | 0.513 |
Blood loss (mL) | 108.0 ± 65.4 | 131.9 ± 30.1 | 131.5 ± 26.6 | 0.092 |
Urine (mL) | 398.0 ± 226.5 | 301.9 ± 197.7 | 380.8 ± 183.9 | 0.199 |
Surgery duration (min) | 174.6 ± 50.2 | 195.2 ± 46.0 | 181.7 ± 42.7 | 0.275 |
Fluid infusion (mL) | 1465.4 ± 386.7 | 1511.5 ± 436.3 | 1536.5 ± 437.6 | 0.833 |
Propofol (mg) | 120.0 ± 21.9 | 119.6 ± 17.5 | 128.3 ± 18.3 | 0.197 |
Fentanyl (mg) | 0.27 ± 0.08 | 0.29 ± 0.08 | 0.29 ± 0.09 | 0.765 |
Cisatracurium (mg) | 20.1 ± 3.7 | 21.0 ± 3.2 | 19.8 ± 3.3 | 0.412 |
Remifentanil (mg) | 0.38 ± 0.13 | 0.46 ± 0.12 | 0.42 ± 0.10 | 0.065 |
Sevoflurane (%) | 2.47 ± 0.37 | 2.44 ± 0.37 | 2.32 ± 0.40 | 0.336 |
Atropine (mg) | 2(7.7%) | 3(11.5%) | 4(15.4%) | 0.690 |
Ephedrine (mg) | 5(19.2%) | 3(11.5%) | 2(7.7%) | 0.448 |